← Evidence map

ArticleJournal of molecular modeling2021

How does nintedanib overcome cancer drug-resistant mutation of RET protein-tyrosine kinase: insights from molecular dynamics simulations.

Shu Cao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2021
2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34725737